Skip to main content
SpringerLink
Log in

ER 30346

BMS 207147

  • Section 2: Antifungal Agent
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fung-Tomc JC, Bonner DP. Recent developments in pradimicin-benanomicin and triazole antibiotics. Expert Opin Investig Drugs 1997 Feb; 6: 129–45

    Article  PubMed  CAS  Google Scholar 

  2. Naito T, Hata K, Tsuruoka A. ER-30346: triazole antifungal. Drugs Future 1996 Jan; 21: 20–4

    CAS  Google Scholar 

  3. Mellsop H. New antifungal agents needed for immuno-compromised patients. Inpharma 1995 Dec 2; 1015: 9–10

    Article  Google Scholar 

  4. Fung-Tomc J, Huczko E, Minassian B, et al. In vitro antifungal activity of a new triazole BMS-207147 (ER-30346). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sep 28–Oct 1; Toronto, 126

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ER 30346. Drugs R&D 1, 170–171 (1999). https://doi.org/10.2165/00126839-199901020-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901020-00013

Keywords

Search

Navigation